References
- Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18:277–81.
- Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 2004;50 :1761–9.
- Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, et al. for the CHARISMA study group. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 2006;54: 2817–29.
- Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X-ray reader-blinded randomized controlled trial of tocilizumab. Ann Rheum Dis. 2007;66:1162–7.
- Ogawa J, Harigai M, Akashi T, Nagasaka K, Suzuki F, Tominaga S, et al. Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanized anti-interleukin-6 receptor monoclonal antibody. Ann Rheum Dis. 2006;65:1667–9.
- Viac J, Pernet I, Schmitt D, Claudy A. Overexpression of cir-culating vascular endothelial growth factor (VEGF) in leukocytoclastic vasculitis. Arch Dermatol Res. 1999;291:622–3.
- Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al. Anti-tumor necrosis factor-a therapy-induced vasculitis: case series. J Rheumatol. 2003;30:2287–91.
- Saint Marcoux B, De Bandtl M. On behalf of the CRI (club rhumatismes et inflammation). Vasculitides induced by TNFa antagonists: a study in 39 patients in France. Joint Bone Spine. 2006;73: 710–3.
- Richette P, Dieu& P, Damiano J, Lioté F, Orcel P, Bardin T. Sensory neuropathy revealing necrotizing vasculitis during Inf-liximab therapy for rheumatoid arthritis. J Rheumatol. 2004;31:2079–81.
- Mohan N, Edwards ET, Cupps TR, Slifman N, Lee J, Siegel JN, et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol. 2004;31:1955–8.
- Tamm M, Bihl M, Eickelberg 0, Stulz P, Perruchoud AP, Roth M. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol. 1998;19: 653–61.